Medscape5h
Noninvasive Stents as Good as Surgery for Triple-Vessel Disease
Advances in PCI over the past decade mean the procedure can now approximate results only previously achieved with open-heart bypass surgery, new data show.
Cardiac stents to cost 2% more as regulator allows prices to be raised
NPPA directed all manufacturers and importers of coronary stents whose retail prices are lower than the ceiling set by it to ...
Prices of coronary stents set to rise
NPPA allows price hike for coronary stents to reflect inflation, impacting heart patients' treatment costs in India.
Medical Dialogues1d
NPPA Revises Ceiling Price of Coronary Stents
According to the new price notified by the drug price regulator, the ceiling price of Bare Mental Stents is Rs 10692.69 & ...
The Financial Express2d
Cardiac stents to become costlier as drug price regulator allows price hike: Report
The life-saving devices will see prices rise by nearly Rs 700 in some cases as the MRP is adjusted for inflation.
Cardiac stent prices could see marginal WPI-linked revision
NPPA allows stent manufacturers to revise prices by 1.74% based on WPI, ensuring compliance with DPCO regulations.
First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension
Monopoint system enables rapid access to the venous systemResearch to be presented at SNIS Cerebral Venous and CSF Disorders SummitSAN MATEO, ...
Zylox-Tonbridge Announces 2024 Annual Results: Achieves Full-Year Profit for the First Time with Net Profit Exceeding USD 14 Million
Zylox-Tonbridge Medical Technology Co., Ltd. (Stock Code: 2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") released its 2024 annual results. In 2024, the Company reported ...